Spots Global Cancer Trial Database for Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections
Official Title: Concordance Study for Amplification Detection of Her2 FISH in Breast Tissue Sections
Study ID: NCT01066507
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is the identification of amplification level in human breast tissue. The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classification of Her2 FISH stained tissue samples.
Detailed Description:
Eligibility
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
PLUS Diagnostics, Lakewood, New Jersey, United States
Scott & White Hospital, Texas, Temple, Texas, United States
Sheba Medical Center, Pathology Dep., Tel Aviv, , Israel
Contact Details
Name: Sheila Dobin, Ph.D.
Affiliation: Section Chief, Cytogenetics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
